A carregar...
Samarium-153-ethylene diamine tetramethylene phosphonate, a beta-emitting bone-targeted radiopharmaceutical, useful for patients with osteoblastic bone metastases
Bone metastases are prevalent among cancer patients and frequently cause significant morbidity. Oncology providers must mitigate complications associated with bone metastases while limiting therapy-related adverse effects and their impact on quality of life. Multiple treatment modalities, including...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3746785/ https://ncbi.nlm.nih.gov/pubmed/23976864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S35789 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|